Quick Answer
TuHURA Biosciences, Inc./NV reported Total Assets of $27.35 million for fiscal year 2025.
TuHURA Biosciences, Inc./NV Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $27.35M | +37.0% |
| 2024 | $19.97M | +221.9% |
| 2024 | $6.20M | +42.2% |
| 2023 | $4.36M | +9.6% |
| 2023 | $3.98M | -75.1% |
| 2022 | $15.95M | +17.8% |
| 2021 | $13.54M | +361.0% |
| 2020 | $2.94M | -27.2% |
| 2019 | $4.04M | -42.9% |
| 2018 | $7.07M | -10.6% |
| 2017 | $7.91M | +24.5% |
| 2016 | $6.36M | +146.8% |
| 2015 | $2.58M | -48.5% |
| 2014 | $5.00M | +15.9% |
| 2013 | $4.32M | +2262.2% |
| 2012 | $182.8K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $25.70M | +520.7% | -25.8% |
| June 30, 2025 | $34.62M | +458.2% | +136.5% |
| March 31, 2025 | $14.64M | +96.6% | -26.7% |
| December 31, 2024 | $19.97M | +959.2% | +382.3% |
| September 30, 2024 | $4.14M | +180.3% | -33.2% |
| June 30, 2024 | $6.20M | +55.9% | -16.7% |
| March 31, 2024 | $7.45M | +10.5% | +295.0% |
| December 31, 2023 | $1.89M | -81.0% | +27.6% |
- TuHURA Biosciences, Inc./NV showed an increase of +37.0% in Total Assets compared to the prior fiscal year.
- Over the 2012–2025 period, TuHURA Biosciences, Inc./NV’s total assets has grown by 14861.0% (from $182.8 thousand to $27.35 million).
- The most recent figure is from TuHURA Biosciences, Inc./NV’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: